Company / Tangible Book Value per Share
Krystal Biotech, Inc. Tangible Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$42.35
FY2025
5-year range
$20.49 / $42.35
FY2021-FY2025
Trend
+26.4%
vs FY2024
Sector context
#10 of 209
Health Care
What the data says
Among 209 Health Care companies, Krystal Biotech, Inc. is in the top 5% for tangible book value per share. Tangible Book Value per Share has increased for 3 consecutive years, from $20.49 in FY2022 to $42.35 in FY2025.
Based on SEC 10-K filings.
42.35 in FY2025 with a 5-year CAGR of +22.2%. Top quartile in the Health Care sector.
Improved from $30.22 to $42.35 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- +27.4%
- 5-Year CAGR
- +22.2%
- 10-Year CAGR
- -
Sector benchmark
-54.7% below sector average
Key checks
Key Insights
- Krystal Biotech, Inc.'s tangible book value per share has grown for 3 consecutive years.
- In FY2025, tangible book value per share increased 26.4% year-over-year.
- Ranks #10 out of 209 companies in the Health Care sector.
- Lowest tangible book value per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 5.66 (safe zone, above 2.9 threshold)
- Strong profit margin: 30.7%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $42.35 | +26.4% |
| FY2024 | $33.52 | +10.9% |
| FY2023 | $30.22 | +47.5% |
| FY2022 | $20.49 | -23.4% |
| FY2021 | $26.74 | +72.0% |
| FY2020 | $15.55 | +21.8% |
| FY2019 | $12.76 | +26.3% |
| FY2018 | $10.11 | +9.5% |
| FY2017 | $9.23 | +2702.3% |
| FY2016 | $0.33 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026